Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Speaking of accumulated deficit. That alone represents significant value for an acquiring company, specifically Zimmer Biomet which would have the best idea of Sintx business, material, etc.. As Sintx has no debt, only assets (offset by small amount of operating liabilities) and this large deficit, an acquiring company would get this large $270m tax offset assuming Sintx can profit as much as its deficit. I of course believe Sintx can for any acquiring company but particular its strategic partners like Zimmer Biomet because its addressable markets are worth upper tens of billions to over $100 billion. 1. Consistent Negativity: One of the key indicators of a stock basher is their consistent negativity towards a specific stock or company. They tend to focus solely on the negative aspects, exaggerating any potential issues or challenges while ignoring positive developments.
No matter which way you look at it, Sintx is so undervalued that it represents significant value for value investors. Caution is of course needed because of the short and distort campaign being waged against it. One need only look at how posters on this forum, outside myself, focus and overly emphasize the negative aspects of the company. They overplay the negative and downplay all the positives if not ignore them altogether, in their posts. All of which is examples of distorting and bashing oriented posting.
https://fastercapital.com/content/Market-Hype--Unmasking-Stock-Bashers--Attempts-to-Manipulate-Buzz.html
========================================
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years. A conspiracy of shorting and distorting.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174597546
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174599544
I go into some of the evidence of this in the February 2023 offering where they drove the price up & naked shorted it down. Ansons family of funds participated in every offering in 2023 up to the recent RS. Anson and the other funds its associated with are known for their short and distort actvity and are under investigation by the DOJ. SEC slapped it with a ticket fine basically that will in no way discourage its shorting and distorting methods.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174602472
========================================
The Value being created at Sintx can be seen in the following posts and links:
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Mantia says investors can also evaluate shareholder value through softer measures such as innovation and competitive dynamics, "which are harder to measure but can be just as important."
For example, a technology company with a strong patent portfolio may be seen as more valuable due to its ability to prevent competitors from copying its technology. Similarly, patents can generate licensing revenue, bolstering a company's financial position. Understanding the strategic value of patents and leveraging them efficiently can positively impact a company's valuation, making it an important aspect to consider in the evaluation of a business.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
You tend to obfuscate the bottomline often my friend, rather than deal with the topic head on. The point I was simply making was that like-minded individuals/ businesses often hang with the same. The "hearsay" was based on the comment from Reddit; a comment that I did not check as to its veracity (but do tend to believe, nevertheless).
Yes madg, we can trust them, can't we? Anyway, good to hear from you as always. Looks to me like the same ol' same ol' from our friends at Sint, only they're limited now from doing their never-ending offerings and reverse splits. I for one, would not advertise that I'm working with Ascendiant to expand my business. IF anything, I would think that would scare any legit firm or knowledgeable investor from looking any further, bwdik? But when you're desperate, you're desperate.....
Boston
Shareholder value is the value given to stockholders in a company based on the firm's ability to sustain and grow profits over time. Increasing shareholder value also increases the total amount in the stockholders' equity section of the balance sheet. A well-managed firm maximizes the use of its assets.
https://www.investopedia.com/terms/s/shareholder-value.asp#:~:text=Shareholder%20value%20is%20the%20value%20given%20to%20stockholders%20in%20a,the%20use%20of%20its%20assets.
Joe that hardly compares to the shit that the conspiracy of hedge funds have been accused and fined for. Have you compared those fines to what a major firm like Blackrock has done? Basically is there such a thing as a fund that hasnt had minor fines? I doubt theyd be worse than what has been going on for the last 9 years of shorting and distorting by Ansons family of funds. You think Sonny is going to be looking to Ascendiant more now and less to Maxim? Have to wonder if Sonny knew if those hedge funds were all interconnected. Hard to believe Maxim wasnt aware of that fact. More on the conspiracy of hedge funds shorting and distorting below. Management’s responsibility, therefore, is to deliver those flows—that is, to pursue long-term value maximization regardless of the mix of high- and low-turnover shareholders.
========================================
Mictrade
Ten Ways to Create Shareholder Value
https://hbr.org/2006/09/ten-ways-to-create-shareholder-value
========================================
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years. A conspiracy of shorting and distorting.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174597546
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174599544
I go into some of the evidence of this in the February 2023 offering where they drove the price up & naked shorted it down. Ansons family of funds participated in every offering in 2023 up to the recent RS. Anson and the other funds its associated with are known for their short and distort actvity and are under investigation by the DOJ. SEC slapped it with a ticket fine basically that will in no way discourage its shorting and distorting methods.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174602472
Never! They lined up the last big m&a with major ortho player CTL! Obviously zimmer is next
Some thoughts on Ascendiant Capital and yes, it's hearsay from my perspective. Still, it should cause one to pause.
Ascendiant and Wedbush both have a history of naked shorting, lock/cross trading, failure to report shorts, and fines by FINRA, SEC, NYSE, and NASDAQ. They're off-Wall Street broker-dealers on the fringes of the securities world. Ascendiant provides "research" for obscure biotech investments that they also promote stock offerings for, so they're essentially a high-class boiler room. Ascendiant also has a fund that is losing money, and they are late reporting last year's results. It seems possible (but not proven) that Ascendiant's investment fund is short on GameStop and trying to stop the bleeding.
"Shareholder" value creation = increase in Shares price ;) i am sure you have missed this word. Since you are usually quite pedantic about sticking to the exact wording but do not adhere to it yourself, it simply shows once again that you just want to push your agenda here.
Point of fact since 2019 when they first engaged Ascendiant Capital, there has been alot of value creation...just not in the dental markets that we are aware of.
Plethora of antipathogenic product candidate.
Armor products/division was added
TAT was added with additional ceramic compositions
Defense was added
Si3n4 imbued PEEK products
Aerospace products
Cancer treatment product(s)
Further development of 3D printing applications.
This isnt even comprehensive. In regards to cancer treatment, it appears the product is optical sensor related. I say that because this part was included in the PR:
The company is also one of the few manufacturers of optical ceramic materials for sensor applications.
More recently, the Company’s femoral head technology has attracted renewed interest from several global partners.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Wow, this 'news' isn't even as good as a letter of intent. The cat's out of the bag. Translation: We desperately need to raise money to continue. Let's get help from Ascendiant. I'm sure they'll find a fair and square partner who won't take advantage of our desperate state.
Not on this planet, Sonny.....sorry that's not how businesses work, especially in a capitalistic society. Expect, Sint to get it's clock cleaned imo.
Sure, like last time when they announced the same. Not sure if we can handle so much shareholder value creation here
With technologies targeted at the medical, defense, and renewable energy markets, year-over-year growth in revenues, and other commercial opportunities in the pipeline, SINTX will require additional investment and resources. As such, we want to examine all strategic opportunities targeted at maximizing shareholder value,” said Sonny Bal, Chief Executive Officer and Chairman of SINTX. “We believe that potential partners will find significant value in SINTX’s businesses and capabilities.”
“Ascendiant Capital”), as investment bank and advisor, to identify strategic opportunities in the dental space.
“While we have been working closely with dental implant companies in specific development projects, Ascendiant Capital will play a critical role in disseminating our R&D advancements to a wider audience of partners, and helping commercialize the technology,” stated Dr. Sonny Bal, President and CEO of SINTX. “We are excited to represent SINTX Technologies, having deep experience and knowledge of dental companies worldwide,” said Dr. Christopher Gayde, a former practicing dentist and Managing Director of Ascendiant Capital’s Dental Investment Banking Group.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Lol i remember a similar news some years ago which resulted in a 99.99 percent loss for shareholders.
Notice how in my post i addressed your points but in your reply you failed to which implies you agree with the points. While you did clarify something, you've manage to change topic away from the points i laid out.
I do not simply defend Sintx, i highlight cons or scams. I do it here. I do it over on Teslas board. I did it on Pernix board as well. Tesla is one of the biggest, if not the biggest, fake it until you make it scam in the world. Pernix, when i was posting on its boards, was being pumped by hired posters. They pumped how it was an acquisition target because its CEO has sold some of his previous companies. The posters pumped this all the while Pernix was in really bad financial shape; loads of debt and drugs that were becoming outdated replaced by cheaper generics. After looking over its financials and filings I declared it would go bankrupt and debated those fund's pumpers for a time. Funds were trying to scam people into buying into their fabrication yet two years later Pernix went bankrupt exactly as i said it would. Tesla is no different but on a much larger scale. I declared Tesla to be a fake it until it makes it scam and shortly after, news of DOJ investigation into it was announced. Not in regards to Tesla cars, that part isnt the scam, but the gross overstatement of how good Teslas self driving tech was and how soon it could deliver robotaxis where owners could make money off their Teslas. Thats still years away if ever. I do not believe Tesla will ever be able to deliver a level 5 network because EM radiation will continue to cause its cars to go out of control and kill people. Something i began to declare in 2021 to much criticism and ridicule. Over time, however, evidence confirming my original hypothesis has only grown...just like the evidence ive collected showing Sintx has very valuable IP, large strategic partners, IP worth a sizable amount, and tech that is game changing. Obviously just recently, i finally showed proof that SINT has been undervalued and manipulated due to a conspiracy of hedge funds that have been shorting and distorting it. Something i have felt was true for years but lacked the evidence. Now its as plain as day!
Like those cons games by funds and even management at Tesla, i have declared that there has been a con here. Not a con to get people to buy as in those two, but the opposite. A con to get people to sell, to run away from SINT and never come back; i however encourage people to keep watching. As ive said, Wallstreet can make a piece of shit company look like a golden goose and a golden goose look like shit. Thats whats happened here. WS has disguised SINT/Sintx as a POS when its in fact a golden goose.
My post showing that Tesla = fake it until you make it scam
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174085276
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
To clarify in my last message, I'm talking specifically about defenders of such stocks like Sint; whereas 'winners' (meaning clearly above board companies) do not have people overemphasizing the 'playing' of the stock price.... These companies just do 'normal' business with various credible institutions and lenders moving them along. There's no constant drama (unlike poorly run penny plays) thrown into the mix all the time as to why the continual under performance. For the most part, if problems do arise, a company will make whatever change is necessary in order to keep the investment community interested and the company a worthwhile investment. Defenders of penny play fails, blame outside forces instead of where it belongs i.e. management, bod, etc. I see it all the time.
is it of your opinion that EVERY institution, EVERY insider and EVERY credible lender feels the same viz that they
show blinders to the value theyve created?
Speaking of variables, is it of your opinion that EVERY institution, EVERY insider and EVERY credible lender feels the same viz that they
show blinders to the value theyve created?
If you are going to properly analyze things here you have to give these variables their proper weight. You have a bias toward management
That's because youre not factoring that Zimmer was already behind the scenes pre-IPO. Thats a significant variable that is a factor here. Just cant say to what degree nor how its impacting things. You know for the longest time I was concerned about hostile parties which prompted Sonny to use various methods to protect Sintx IP. Anson femily of funds could be a hostile variable. Just depends if they are serving any interests other than their own.
What we can agree on is Sintx IPOd to use public markets to further fund development of IP and to derisk it more.
If you are going to properly analyze things here you have to give these variables their proper weight. You have a bias toward management and continue to show blinders to the value theyve created. You're also downplaying the impact the conspiracy of funds have had on the stockprice and Sintx image, shifting that blame to management, as funds continue to short and distort. I know youre going to say that i have a bias towards management, though it may seem that way, i can consider various angles but there lacks sufficient evidence. I am aligned with Sonny as long as he continues to develop Si3N4 IP for its eventual acquisition while Sintx is public. Im not aligned with Sintx going private again as ive said before. Private companies rarely have the resources to fund the cost of development. Hence why Sintx went public.
It had to be at least 20 years ago when I first heard that bad management made EVERY stock non investment material, regardless what it had to offer. I have found this to be continually true. I find it to be true concerning Sint. You and I disagree on whether or not it is properly managed. Therefore I do not believe "there's something else that holds them back"....
I have trouble believing they do not "trust" management simply because its managements connections that play a significant role in why Sintx could be worth as much as it is. I think theres something else that holds them back for now...
I find it interesting that you seem to exaggerate the role management plays in the state of its stock while downplaying the positives they bring to the company along with the value theyve created. You do this while also downplaying the game the shorters & distorters play. Im not talking the leech shorters that join in for the ride, i mean the main players manipulating the stock downwards. I think Anson's group of hfunds is here serving a purpose, the question is who's purpose? If they drop the stock enough they'll lower the strike price of my warrants so you'd think i'd want them to reduce my costs. Yet i fight against my own self interest because Sintx needs to be properly valued like yesterday and the tech development/commercialization going asap! The tech is too important for the future!
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Since you included me, the truth is I simply don't know. However, those that are in the know (the Bank of America types; credible investment firms etc) don't seem to think so, otherwise they'd invest. Now, for argument's sake, let's say you are correct. Then the only reason these loan/ investment vehicles refuse to enter in (to something they know is worth north of a billion) would be because they don't trust those managing the IP. They're intelligent enough to know how NOT to lose money on alleged winners. Sint remains a loser mainly because of management. The gamers and shorters and distorters (if you will) just take advantage of the gift that's freely given to them.
Joev2 still hasnt answered my question if Sintx IP is worth more than 1 billion based on its addressable markets and known/suspected strategic partners.
TA, you are going to have to do better than using truth to tell lies; precisely what people engaged in disinformation/short & distort campaigns do. You claim that Sintx is a share dilution scam because Sintx has to raise funds to continue operations. That is not a share dilution scam per your reference.
What has happened here is due to the short and distort campaign taking advantage of the fact that Sintx needs to raise money to fund R&D; which leads to it overly diluting with each offering and then reverse spliting to stay listed. Is my description of what has occurred the last 9 years accurate or yours? First off, for Sintx to be a share dilution scam it would need to raise funds just because. There is little detail on this sort of scam so im going to go out on a limb and assume there is not much of real value being created on the company side that is involved in these sorts of scam.
Why Sintx/SINT cannot be a share diluting scam!
During Sonny's tenure as CEO, Sintx IP has grown significantly, something you cannot honestly deny. Meaning Sonny has overseen, partially created as well as hes a contributing scientist, a massive expansion of Sintx product candidates branching off into many new possible markets. From Cancer to Anti-pathogenic to Aerospace/Defense to many other possible uses just within the ortho/medical sector. So no Sintx cannot be a share dilution scam for the simple reason so much value has been created but for reasons i already shown, that value is not reflected by the markets because Sintx has been under a short and distort campaign for 9 years as i show in links below. Sintx market value should exceed $230m. So why is it currently worth $3.5m? I dont just claim this, anyone can verify that a comparable materials company was acquired for 230m by Zimmer back in 2003. As Sintx material is superior to that of Implex Hydrocel, has more strategic partnerships in place with at least 2 large companies, & can be used in so many additional markets in addition to the ortho market, its worth more than $230m. In fact Joev2 still hasnt answered my question if Sintx IP is worth more than 1 billion based on its addressable markets and known/suspected strategic partners.
In conclusion, Sintx/Amedica, cannot be share dilution scam for the simple reason that too much value been created with the funds raised. Instead evidence suggests SINT only APPEARS to be a share dilution scam because of the conspiracy of hedge funds engaged in a short & distort campaign against it for 9 years.
https://stocktwits.com/TAman87/message/576726282
========================================
This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years. A conspiracy of shorting and distorting.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174597546
This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174599544
I go into some of the evidence of this in the February 2023 offering where they drove the price up & naked shorted it down. Ansons family of funds participated in every offering in 2023 up to the recent RS. Anson and the other funds its associated with are known for their short and distort actvity and are under investigation by the DOJ. SEC slapped it with a ticket fine basically that will in no way discourage its shorting and distorting methods.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174602472
========================================
The Value being created at Sintx can be seen in the following posts and links:
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Pitk account seems to be part of the short n distort campaign. Either that or they want to be seen as part of it. They like to use me as a scapegoat for their actions.
Deckmaxx = Boston, be wäre the main pumper is on board
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
There is a specific SEC rule against short selling stock just before a public offering and then buying back the stock in the offering
(3) Investment companies. Paragraph (a) of this section shall not prohibit an investment company (as defined by Section 3 of the Investment Company Act) that is registered under Section 8 of the Investment Company Act, or a series of such company (investment company) from purchasing an offered security where any of the following sold the offered security short during the Rule 105 restricted period:
(i) An affiliated investment company, or any series of such a company; or
Together with a strategic partner, we have initiated biomechanical testing of our solid silicon nitride femoral heads. The results of this test will be released in 2017
Amedica and Zimmer-Biomet (Tokyo Office) provided the femoral heads and acetabular liners; however, neither company actively sponsored the research
These are risk-averse companies that look to smaller companies like us to develop an idea, uh, and, uh, de-risk it, so to speak, and then buy that technology.
This is essentially how the Anson family of funds (is Anson at the top of this family?) work SINT and its offerings.
Here is a trade that is almost guaranteed to make money, though it is also double super illegal.
These companies -- there were 13 of them, all pretty small -- raised money through what the SEC calls "confidentially marketed public offerings." A company would engage an investment bank, which would call up potential investors and ask if they wanted to buy shares in the company. The bank would do this before the company publicly announced the offering, and would "wall-cross" the potential investors, making them agree to keep the information about the offering secret until it was announced publicly.
So here's a predictable stock-market pattern and an easy way to exploit it: If a company calls you up to ask you to invest in its upcoming public offering, you should (1) say yes, (2) sell the company's stock short before the public announcement, and then (3) buy the stock back in the public offering, generally at a 10+ percent discount, a few days later.
This is of course not legal advice! It is a great trade, but it is also double super illegal, insofar as:
There is a specific SEC rule against short selling stock just before a public offering and then buying back the stock in the offering, 5 and
There is a general, and much more important, rule against trading on purloined material nonpublic information, and this is that.
trading in breach of that agreement, you are clearly violating not just the contract, but also insider trading laws, which make it illegal to trade "in breach of a fiduciary duty or other relationship of trust and confidence, while in possession of material, nonpublic information about the security."
But, you know, who will check?
Some of the funds would get wall-crossed, and then they'd tip each other and trade in the other funds to try to obscure what was going on:
When they were successful in obtaining such information, Fishoff shorted the issuer’s stock in advance of the offerings, directed trading by Chernin and Costantin in those instances when he did not place the trades on his own, and tipped Petrello, who then also shorted the stock through Brielle and Oceanview.
In many instances, the Fishoff-controlled entities for which Chernin and Costantin were fronting also participated in the offering, with the stock going to Featherwood’s account and often being used to cover the short sales.
By cheating on their wall-cross agreements and shorting the stock, these guys had the effect of driving down the stock price, which probably reduced the price in the offering. These companies probably got less money for their stock because their nonpublic information was (allegedly) used against them.
Though you could have a more cynical view of this sort of thing. A company needs to sell stock, but worries that announcing a public offering will drive down its stock price and not produce any takers. So it calls some investors up privately and tells them it's doing a deal. Those investors agree to invest in the deal, but before the deal is announced they lay off their risk by shorting the company's stock. Then the deal is announced and the investors buy shares from the company to (illegally) cover their shorts. The investors get their 10 percent, or whatever, discount to the market price as a commission; their real function is not to invest in the deal but to intermediate between the company (which can't sell stock without a publicly disclosed offering) and the unsuspecting public (which buys from the "investors" before the public disclosure). The wall-cross agreement creates deniability for the company. No one's stealing from the company; they're helping the company get a deal done that would otherwise be much harder to achieve. The victims are the public who buy from the insider traders at the inflated, pre-announcement price.
The 10000 can be wash traded back and forth freely between colluding computers. Tons of money is made so they can now walk the stock down even lower because risk has been reduced.
In my opinion, Anson and his ilk are nothing but gamers AND Bal (with the help of management and the bod of do-nothings) made it exceptionally easy for them. I've said it many times. When you don't come through in your news releases; never address your shareholders (let alone even acknowledge they exist); have ONLY CLOSED conference calls or skip them all together during earning season, you give NO incentive whatsoever to invest. However, you completely open the doors for the shorters (smart people) and the gamers (also smart people) to have a field day....and a field day, they did!
I'll also add, the numerous offerings and reverse splits ALL BEING AFTER the stock was ALREADY down 99%, didn't help. I personally can only come to one of two conclusions about management: a) corrupt; b) clueless.
Boston, thank you for being so detailed oriented. It's interesting how the Ansons of the world work.
Things just go SOOOO much more interesting with this revelation. It shows there has in fact been a conspiracy of funds, shorting and distorting Sint & Sintx since 2015. My next post will give some insight into how this family of funds might operate. This includes shorting before offerings exactly as ive said was occurring but it looks like the other funds do the shorting and then cover with the shares the fund that bought the offering received. Also seems to include wash trading back n forth just like Xenalives has posted in the past.
Plaintiff further asserts that many of the potential investors that it contacted on behalf of Defendant operate as a family of hedge funds, all managed by the same investment advisor.
List named the following:
• Anson Funds Management LP and its affiliates
• Ayrton Capital, Altos Opportunity Fund and their
affiliates
• Crede Capital Group, Acquitas Capital and its affiliates
• CVI Investment, Heights Management, SIG and their
affiliates
• Connective Capital and its affiliates
• Empery Asset Management and its affiliates
• Intracoastal Capital LP and its affiliates
• Hudson Bay Capital Management and its affiliates
• Ionic Venture LLC and its affiliates
• Lind Partners and its affiliates
• Li Capital Global Opportunities Master Fund and their
affiliates
• Sabby Management LLC and its affiliates
This Schedule 13G (this “Schedule 13G”) is being filed on behalf of Frigate Ventures LP (d/b/a Anson Group), a Texas limited partnership (“Frigate”), Admiralty Advisors LLC, a Texas limited liability company (“Admiralty”), Mr. Bruce R. Winson, the principal of Frigate and Admiralty, M5V Advisors Inc. (d/b/a Anson Group Canada), an Ontario, Canada corporation (“M5V”), Mr. Adam Spears, a director of M5V, and Mr. Moez Kassam, a director of M5V, relating to Common Stock, $.01 par value (the “Common Stock”), of Amedica Corporation, a Delaware corporation (the “Issuer”).
For years ive been speculating that there was an activist investor behind the scenes with Sintx and Anson Fund could be just that for which Sonny has been trying to protect Sintx from. Its a fund that's participated in offerings with a investment manager thats been tied to Sintx offerings since 2015; Mr. Moez Kassam, co-founder of Anson but investing via M5V in the 2015 offering (linked below). If Anson and Kassam were behind any campaigns to short and distort Sintx, then all those bashing Sintx on stock forums, are helping (knowingly or not) such a short and distort scheme.
There have been claims, particularly on ST, Sonny was in bed with Kassam/Anson. Maybe they meant Sunny Puri one of Ansons analysts? Naturally there has been no disclosed evidence to substantiate such statements of Kassam/Anson & Sintx CEO, just baseless claims. Here is an article on an alleged campaign orchestrated by Anson Fund. Its interesting that those bashing Sintx invoke Anson Fund to in such a manner to scare people away from SINT.
Catalyst Capital Group Inc. has launched a lawsuit against Anson Group Canada, a privately held asset manager with operations in Canada and Texas, and Toronto-based private equity firm West Face Capital Inc., accusing them of participating in a “manipulative ‘short and distort’ campaign.”
The alleged target was publicly traded Catalyst subsidiary Callidus Capital Corp., claims the lawsuit, which dubs the Anson, West Face and several associated and unrelated individuals as “Wolfpack Conspirators.”
The lawsuit, filed Tuesday in Ontario’s Superior Court of Justice, claims the group targeted Callidus with a short-selling strategy that involved coordinating with and providing financial support to a group of borrowers who had defaulted on loans to Callidus, and were fighting to prevent Callidus from collecting.
It also alleges use and attempted use of the news media to further their short-selling campaign, improper use of a new regulatory whistle-blowing program, and coordinated buying and selling of shares.
Among others, the lawsuit also names Anson principals Moez Kassam and Adam Spears and analyst Sunny Puri,
The minor nature of the infraction and the small size of the settlement was far from the grand hype that surrounded the investigation, which was said to involve dozens of short sellers, and numerous companies, including some blue-chip names. One fund manager called the SEC settlement with Anson “a consolation prize for some ticky tack bullshit.”
"Anson has a long history of driving differentiated and uncorrelated returns - activism is a natural extension for us," Anson's founder and chief investment officer Moez Kassam told Reuters.
The firm plans to work behind the scenes with target companies but is ready to launch public campaigns, including pushing for board seats for Gupta and others, the company said.
Mr. Adam Spears, a director of M5V, and Mr. Moez Kassam, a director of M5V
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Air Canada plane makes emergency landing at Sacramento International Airport after engine failure
An engine failure aboard an Air Canada Express commuter flight from Sacramento International Airport caused the pilots Tuesday to turn around and return to the capital city’s airport. The plane — Air Canada Express flight 7121 — took off bound for Vancouver, British Columbia, about 40 minutes late at 9:52 a.m., according to FlightAware, an online plane tracking system. The plane operated by Jazz Aviation is a CRJ-900LR, a regional jet that seats 76 passengers, and was built by Bombardier in 2005. However, the small jet’s left engine, a General Electric model CF34-8C5, failed shortly after takeoff and a crew of four people aboard was diverted. The jet safely landed about 10:35 a.m., according to archived audio dispatch calls reviewed by The Sacramento Bee.
SINTX has a long history of developing composites and coatings for extreme environments. Our 30 years of experience has allowed us to gain expertise with both C and SiC fibers, debond coatings including carbon and SiC, dozens of different options for the composition and the production process for the ceramic matrix, and a wide array of final barrier coatings.
Our Ceramic Matrix Composite (CMC) experience initially was focused on Carbon/SiC and SiC/SiC based formulations, but this material family has a wide array of options which tailor the properties such as density, strength, oxidation resistance, and wear resistance.
1. Consistent Negativity: One of the key indicators of a stock basher is their consistent negativity towards a specific stock or company. They tend to focus solely on the negative aspects, exaggerating any potential issues or challenges while ignoring positive developments.
You and Sint should be proud! Of all the investors ANSON (and we know who he is) owns by far, the most LOL. If that doesn't say anything I don't know what does (but you alone do, of course). Like I said, no one wants Sint; no one is willing to invest in Sint. But sure, if one can freely pick apart the carcass....
This says otherwise. Some big names keeping small positions in Sintx and have been for years. Only requires 1 share to request info from management. Theyve been keeping an eye out on Sintx for a reason...
2024-05-20 13F Virtu Financial LLC 0 -100.00 0
2024-05-15 13F Bank Of America Corp /de/ 0 -100.00 0
2024-05-15 13F Tower Research Capital LLC (TRC) 9,481 572.89 0
2024-05-15 13F Two Sigma Securities, Llc 84,812 736.08 4 33.33
2024-05-15 13F Morgan Stanley 2,228 -0.09 0
2024-05-15 13F State Street Corp 17,293 0.00 1 -100.00
2024-05-14 13F Anson Funds Management LP 959,297 47
2024-05-13 13F Geode Capital Management, Llc 21,894 -1.61 1 -87.50
2024-05-13 13F Hrt Financial Lp 17,967 0
2024-05-13 13F Fmr Llc 41 0
2024-05-10 13F Vanguard Group Inc 43,409 0.00 2 -87.50
2024-05-10 13F Wells Fargo & Company/mn 42 27.27 0
2024-05-10 13F BlackRock Inc. 0 -100.00 0
2024-05-10 13F Jpmorgan Chase & Co 29 3.57 0
2024-05-10 13F Advisor Group Holdings, Inc. 18 -5.26 0
2024-05-08 13F Heritage Wealth Advisors 524 52,300.00 13
2024-05-07 13F Cornerstone Planning Group LLC 1 0.00 0
2024-05-03 13F Signaturefd, Llc 573 0.00 0
2024-05-02 13F Kestra Private Wealth Services, Llc 10,000 0
2024-05-01 13F Proequities, Inc. 0 0
2024-04-25 13F Allworth Financial LP 1
https://fintel.io/so/us/sint
This continues and will always be your problem. You deflect from the real issue I.e. NO ONE INVESTS and instead focus on the word 'joke' which is neither here nor there. Would it help if I said 'great company' instead? No. The point is and was and apparently will remain which is, no one invests, period.
Now enjoy picking apart the hidden meaning in this message and why the company is this and that and worth this and that. No one invests, regardless....and who really cares about the rest? No one but you and that's why your $110000 five years ago is worth $5 today. That's the REAL issue. So play the disinfo game all you want and who's working together with whom. Doesn't change the real issue here: no one wants Sint.
Absolutely NO INVESTMENT FIRM, INSIDER or credible lending institution takes Sint for anything other than the joke that it is; hence it is left alone.
This contract will address material challenges in propulsion and guidance technology for next generation high-temperature Department of the Air Force systems.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Before i get into Zimmer and Sintx, and not that i actually said Sintx would be acquired for $1+b, do you think Sintx IP could be worth north of a B based on addressable market size and several of its known/possible partner companies? It is worth over $230m based on comparable company and its material and its used $270m developing the tech. Public companies are generally worth more than their private counterparts and the ortho market has grown substantially since 2003. I would like to know what product is being worked on that Si3n4 can be used for Cancer treatments? Thats just 1 market that Si3n4 can play in that Implex Hydrocel couldnt.
List of Markets Sintx can participate in and products in development:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174489883
========================================
I didnt say conclusions were facts. The facts are someone posted Zimmer intends to acquire Sintx, then Amedica, for its tech and this was posted 3 years before Sintx went public so it was not an attempt to pump SINT/AMDA. Furthermore, mentions of Zimmer within Sintx IPO paperwork were removed indicating someone didnt want it widely known Sonny & previous chairman had ties to Zimmer. Since that time Zimmers actions have been consistent with this statement including being a strategic partner with Sintx testing its femoral head as evidence by the following verifiable evidence and hiring of a Si3N4 expert in Dr Lal.
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
Together with a strategic partner, we have initiated biomechanical testing of our solid silicon nitride femoral heads. The results of this test will be released in 2017
Amedica and Zimmer-Biomet (Tokyo Office) provided the femoral heads and acetabular liners; however, neither company actively sponsored the research
These are risk-averse companies that look to smaller companies like us to develop an idea, uh, and, uh, de-risk it, so to speak, and then buy that technology.
Rule 5815(d)(4)(A), entitled “Hearings Panel Monitor,” provides a Hearings Panel with
discretion to monitor a company for a period of up to one year after the date a company regains
compliance with a listing standard if it concludes that there is a likelihood that a company will
fail to maintain compliance with one or more listing standards during that period (including
requirements with which the company was not previously deficient). During this one-year
monitoring period, Staff will monitor the company, to confirm compliance with all listing
requirements. While Staff monitors all listed companies for compliance with the Exchange’s
listing standards, if Staff identifies a deficiency with any listing requirement for companies that
are being monitored under Rule 5815(d)(4)(A), staff may not provide the company with a cure or
compliance period, nor the opportunity to submit a plan to regain compliance with the
deficiency. Instead, Staff will issue a Delisting Determination for these companies.
Looks to me like Sint's game will finally expire. They have approximately 11 months to stay consistently over a buck. If we are to follow its history, once it goes under a dollar, it may have up to a week, bouncing above and below, before it's below for good. Boston is correct that management MUST get on board, even if only to feign interest. That in itself may not do the trick, though.
Truth is, this time if they stay under, they get delisted: no more freebies from nasdaq to play the shareholders. Wonder the timing of Bal's announcement? Stay tuned, folks. Looks like we'll finally see whether or not Sint can ACTUALLY get it going. I believe not, but we'll soon find out. They can always go private but what does that do for those that trusted this was a sound investment?
I'm sure at least one individual will still absolve management of all wrongdoing, but if correct, facts will once again prove that management at best WAS clueless in taking this public in the first place, and remained clueless throughout. Prove me wrong, Sonny.
The nasdaq thingy you're referring to. Notice the date....
https://www.sec.gov/files/rules/sro/nasdaq/2021/34-93789.pdf
All these conclusions you come to based on connecting dots (what you call facts) are YOUR OPINIONS ONLY, which is NOT supported by ANY investor of ANY category (you're free to consider those shorting every conclusion of yours, as a category). Obviously NOTHING is connecting as you envision and have envisioned for years (remember the billion dollar buyout?).
Haven't checked whether or not the following is actually factual or not, but I'm quite sure they're close! According to our very own IHUb, Sint is down from a high of $110,000 per share five years ago to $5 per share today. So you can enjoy all your subjective analysis all you want. No one but you is following it. THAT is a fact! Absolutely NO INVESTMENT FIRM, INSIDER or credible lending institution takes Sint for anything other than the joke that it is; hence it is left alone. Oh yes, fact is Maxim types LOVE the Sints of the world. Oh, and btw, thank you for the shared Info from the Nasdaq. Apparently, they're onto Bal and Sint as well. Good job, Nasdaq....sure took you long enough.
This is new and means things will have to be different going forward. Even more reason if there is going to be another offering, management needs to buy shares to help support the stock price. They cant just raise funds and let markets continue to naked short the stock. Is this a new thing being done by Nasdaq? This would also be another reason for 200:1 RS ratio over 100:1. BTW this is good news for investors, for the next year at least, as funds have incentive to keep this trading over 1 now!
The Company remains subject to a “Mandatory Panel Monitor,” as that term is defined in Listing Rule 5815(d)(4)(B), for a period of one year from June 11, 2024. If, within the one-year period, the Company fails to satisfy the minimum $1.00 closing bid price threshold for 30 consecutive business days, Nasdaq will issue a delist determination rather than provide the Company with a grace period to regain compliance with the Bid Price Rule. In that event, the Company would have the opportunity to request a new hearing to address the deficiency.
Unlike misinformation, disinformation is false information that is designed to mislead others and is deliberately spread with the intent to manipulate truth and facts.
Unlike misinformation, though, the foundation of disinformation is malicious and deceptive.
Right and when you post 'motives' or 'aliases' or 'a working together' regarding others, that's not disinformation. When you state with certainty based on a subjective viewpoint that it's manipulation or a conspiracy because SOME individuals use common sense and short the crap out of this stock, that's not disinformation. Their only other choice in investing would be to 'buy' and do what you do, promote the company and it's so-called 'facts' while ignoring 'other facts' that show the company is run like a piece of crap. But hey, that's not disinformation or a conspiracy either.
And you know what? Maybe you're correct. Maybe it can't be a conspiracy (although it's still disinformation) because apparently, you're the ONLY individual who believes the crap you're spewing. As for the intentions of Zimmer, Bal, Sint and whomever, the fact that nothing of substance has EVER truly materialized, that's not a conspiracy or a working together either. Keep going. After all, as long as you can keep convincing yourself, you win! But (ahem), there's one problem....
Joe, theres the big difference between us. I post verifiable facts about the company and your posts continue to contain disinformation. Why is that?
TA I'm still not convinced you're not correct with the 'paid shill' comments. It's mind boggling to say the least, how one can STILL defend the indefensible viz management, without they themselves being part of the game plan
When one takes away the conspiracy notion (various alleged manipulations don't make a conspiracy, but they can show astute awareness to scammy-type operations) and 'bubbles'
Conspiracy comes from the Latin word conspiratio. While conspiratio can mean "plot" or "conspiracy", it can also be translated as "unity" and "agreement",
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
Together with a strategic partner, we have initiated biomechanical testing of our solid silicon nitride femoral heads. The results of this test will be released in 2017
Amedica and Zimmer-Biomet (Tokyo Office) provided the femoral heads and acetabular liners; however, neither company actively sponsored the research
These are risk-averse companies that look to smaller companies like us to develop an idea, uh, and, uh, de-risk it, so to speak, and then buy that technology.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
TA I'm still not convinced you're not correct with the 'paid shill' comments. It's mind boggling to say the least, how one can STILL defend the indefensible viz management, without they themselves being part of the game plan, while stating or insinuating everyone else is. I've been accused or it's been insinuated, I'm part of a certain 'group', use various aliases; not to mention, having posts deleted left and right over the years, over the slightest 'off-topics'. I'm soooo thankful I-Hub wised up OR some individual reported it all.
When one takes away the conspiracy notion (various alleged manipulations don't make a conspiracy, but they can show astute awareness to scammy-type operations) and 'bubbles' (inverse and otherwise), one can easily deduce that Sint has been poorly managed, poorly represented, and taken advantage of by greedy management (with the help of its cohorts such as Maxim) and served to the investing public on par to hardly anything I've EVER seen (yes, the emphasized part is subjective)!
The result: years upon years of lousy earnings, fake or misleading "news" events (O2 comes to mind), followed by the inevitable 'offerings', reverse splits etc, prove the statement "you reap what you sow". Sint and its ilk have traded and continue to trade, and WILL ALWAYS continue to trade similarly in the future, UNLESS drastic change within, occurs.
Unfortunately, the common sense approach to investing will continue to prove evasive for some. In its place will be fantasies, conspiracies, manipulations and now 'inverse bubbles' in hope that at least ONE will somehow slow down the miserable trajectory, stocks like Sint deservedly are on. Fortunately, most of us learn from our foolish mistakes; others sadly, never do. To those who foolishly and stubbornly remain on such a course, all I can say is, keep investing! Eventually when you lose all your resources to invest with, it is my hope you will no longer bring others or encourage others to throw away their money, as you have done. So, there is a possible silver lining after all, even with a Sint!
Top economist predicts ‘crash of a lifetime’ worse than 2008 recession
Mr Dent and I agree on most things. Bubbles burst and this is the mother of all bubbles. This should have occurred already based on historical patterns of 7-15 year bull/bear cycles. Somehow they have delayed this into 2025, post election?
Speaking in an updated interview with Fox News Digital, Dent cautioned that the “everything” bubble still has not burst, and it may be a bigger crash than the Great Recession.
Looking at it from history and standing back, nothing’s more obvious,” Dent continued. “A lot of other bubbles in history just do not have the steepness or the magnitude. Why? We’ve never realized the power that central banks can have to just print money out of thin air.
And again, this bubble has been going 14 years. Instead of most bubbles [going] five to six, it’s been stretched higher, longer. So you’d have to expect a bigger crash than we got in 2008 to ’09.”
“The government created this bubble 100% … totally artificial, injecting a drug to artificially perform stronger. And again, everything from human life to history shows, you don’t get something for nothing, and bubbles always burst … it’s a much, much higher possibility than anybody gives it.”
“This is going to wash all this excess out of the markets, bring the markets down to where they should be so that the millennial generation can have a boom that is healthier and that they can invest their savings into for retirement.”
In a bubble, prices become disconnected from values because purchasers believe that, whatever the fundamentals, they will soon be able to sell what they have bought at a higher price. The bubble must burst eventually because the supply of new people willing to buy at ever higher prices will be exhausted, and generally bursts sooner than that because people come to realize this.
In the opposite of a bubble, prices become disconnected from values because sellers believe that, whatever the fundamentals, they will soon be able to buy what they have sold at a lower price. The anti-bubble must also eventually collapse because the supply of new people willing to sell at ever lower prices will be exhausted.
While propaganda and disinformation have long been used by malign actors to intentionally mislead and manipulate the public, disinformation online can spread fast and far across networks anonymously, cheaply and efficiently, making it a challenging problem to address. The internet and social media platforms have become “weaponized” to purposefully confuse, agitate and divide civil society
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Three more for the hearsay crowd: 1) stock's tanking; 2) Boston's defending; 3) virtually everybody's mocking. I wonder why? Let me look for some evidence....sans common sense.
Anal retentiveness is a personality trait that is characterised by excessive concern with trivial details.[1] The concept originated in Freudian psychoanalytic theory, where one aspect of the anal stage of psychosexual development is pleasure in the retention of feces. Fixation in this stage can potentially result in a personality marked by frugality, obstinacy and orderliness.[2] Despite its psychoanalytic roots and the literal meaning of the words, in common usage the term generally refers merely to certain kinds of obsessive behaviour.
I simply asked for some evidence which you are declining to provide. Thus what you are claiming is pure hearsay. The rest of your post is typical disinformation with the exception of one statement where you claim there is evidence that there is something wrong with Sintx. What evidence indicates this? If you have to point to the stockprice as evidence or lack of management buying yet then you clearly have no real evidence there is something wrong with the company. Those only imply there is something wrong without anything of actual substance. If you wanted to make people believe theres something wrong with the company it is an effective method against those who do not look deeper.
Disinformation Techniques employed:
I have learned that you do not change positions regardless the evidence shown.
Therefore Sint apparently is the ultimate victim of sinister forces extending all the way through message boards.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
You're asking the wrong source. Ask those who know the field and are on record as saying something is 'different' with this virus. Ask China why they stonewalled any type of investigation since it's so obvious that it was naturally occurring through the Himalayan mountain range; ask why it occurred where it was traced to and why records were destroyed etc.....
In any event it doesn't matter. I have learned that you do not change positions regardless the evidence shown. This is why you cling so tenaciously to Sint despite continual evidence that there's something VERY WRONG with this company (regardless where the blame lies). But again, not to you. Therefore Sint apparently is the ultimate victim of sinister forces extending all the way through message boards. Meanwhile....
Joe please provide some actual scientific evidence that suggests the virus was man-made. Here is the study indicating that Himalayan mountain range is best location for new viruses to come down from the upper atmosphere due to how thin the stratosphere is. This study indicates that new microorganisms are coming from space which could enter via cracks in the magnetic field that send plasma out into space. When the magnetic field reconnects it pulls that plasma back into the upper atmosphere cooling it and possibly bringing new microorganisms with it. Its in the upper atmosphere the viruses are muting due to the higher amounts of radiation. I also recall reading another study that showed how terrestrial organisms get into the upper atmosphere and mutate due to that radiation. Which would then come back down to the lower atmosphere by the thinner stratosphere. This seems more likely than organism from a passing comet. Another mechanism that could bring viruses down from the stratosphere in other places other than the Himalayan is 'Day After Tomorrow' like storms where the literal cold air from the stratosphere is funneled down to the surface via the storms vortex. There was such a storm this year that occurred in Feb in China. Temps dropped 50 C freezing fish and birds in their place.
It is also of interest to note that the first descent of viral-sized particles deposited in the stratosphere will occur at places where the stratosphere is thinnest; and by this argument populated areas of China lying eastward of the Himalayan mountain range would present the best candidates. It is therefore not surprising to find that first strikes of new or renewed viral diseases are often recorded in China. We should however stress that not every minimum in the sunspot cycle would be associated with a new epidemic or new pathogen. Additional conditions need to be fulfilled, most importantly that the Earth has recently encountered a stream of cometary debris containing disease-causing dust-e.g. phages, virions, microorganisms.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
lol - THIS time it's different. The price is being manipulated lower so management can buy in cheap.
ROFLMFAO
Followers
|
240
|
Posters
|
|
Posts (Today)
|
6
|
Posts (Total)
|
41295
|
Created
|
02/13/14
|
Type
|
Free
|
Moderators Atlanta1 Tesla thru the roof |
https://www.youtube.com/watch?v=j94SgeyCh3M
(AMDA) Amedica Corp. - NASDAQ
RECENT NEWS
https://www.youtube.com/watch?v=hxbj7Sq7W94
https://www.youtube.com/watch?v=j94SgeyCh3M
https://www.youtube.com/watch?v=KbU47COpXx8
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |